Results 51 to 60 of about 272,839 (312)

Adherence to the enhanced recovery after surgery protocol and outcomes after colorectal cancer surgery. [PDF]

open access: yes, 2011
Objectives: To study the impact of different adherence levels to the enhanced recovery after surgery (ERAS) protocol and the effect of various ERAS elements on outcomes following major surgery.
Hausel, J   +6 more
core   +3 more sources

Clinical Association of Negative Lymph Nodes With Adjuvant Chemotherapy in Patients With T3N0 Rectal Cancer

open access: yesGastroenterology Research and Practice
Conclusion: NLN count is an independent prognostic factor in patients with T3N0 rectal cancer. Patients with low NLN counts (NLN 
Dongxu Lei   +12 more
doaj   +1 more source

Pathways of lymph node metastasis and prognosis after right hemicolectomy for cecal cancer: results from a retrospective single center

open access: yesWorld Journal of Surgical Oncology, 2023
Background The recommended operation for cecum cancer (CC) is right hemicolectomy (RH) in some Western countries while the principle of D3 lymphadenectomy in Japan recommends resecting approximately 10 cm from the tumor edge.
Liang Yu   +8 more
doaj   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau   +8 more
wiley   +1 more source

Quality of life and chronic pain four years after gastrointestinal surgery [PDF]

open access: yes, 2006
PURPOSE: Little is known about the prevalence of chronic postsurgical pain after gastrointestinal surgery. This study was designed to assess the prevalence of chronic pain and quality of life in a cohort of patients who underwent surgery for benign and ...
Krukowski, Zygmunt H.   +2 more
core   +1 more source

Contemporary Issues in Colorectal Surgical Practice [PDF]

open access: yes, 2012
In recent years, significant progress in colorectal surgery has been made which includes laparoscopic techniques, pre-operative management, emergency colorectal surgery, fast track multimodal recovery, management of complex wound problems and colorectal ...

core   +3 more sources

An Unusual Case of Ileitis and Partial Small Bowel Obstruction Secondary to Mesh Erosion After Totally Extraperitoneal Inguinal Hernia Repair

open access: yesCase Reports in Gastrointestinal Medicine
The objectives were to highlight that: (1) mesh erosion related partial small bowel obstruction after laparoscopic totally extraperitoneal (TEP) inguinal hernia repair (IHR) as an uncommon complication can clinically and radiologically mimic ileocolic ...
Pranesh de Silva   +5 more
doaj   +1 more source

A comparative study on efficacy and safety of modified partial stapled hemorrhoidopexy versus conventional hemorrhoidectomy: a prospective randomized controlled trial [PDF]

open access: yesAnnals of Coloproctology
Purpose The long-term outcomes and efficacy of partial stapled hemorrhoidopexy (PSH) compared with those of conventional hemorrhoidectomy (CH) are not fully understood. This study aimed to introduce a modified PSH (mPSH) and compare its clinical efficacy
Tae Gyu Kim   +10 more
doaj   +1 more source

A review of 14 cases of perianal Paget’s disease: characteristics of anorectal cancer with pagetoid spread

open access: yesWorld Journal of Surgical Oncology, 2023
Background Perianal Paget’s disease (PPD) is an intraepithelial invasion of the perianal skin and is frequently associated with underlying anorectal carcinoma.
Jun Imaizumi   +5 more
doaj   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy